- G80, H12, W99 -

HOME TRIMETHYLAMINURIA CLINICAL RESEARCH TESTING DONATIONS BLOG MENTAL HEALTH WELCOME TO MEBO RESEARCH CURRENT NEWS INFORMATION 2018 IMPORTANT OFFICIAL MEBO RESEARCH CLINICAL TRIALS MEBOs Mission is to initiate research into rare genetic metabolic diseases particularly those resulting in systemic difficult to control body malodor and halitosis including but not limited to Trimethylaminuria. Studies such as theDynamics of the Gut Microbiota in Idiopathic Malodor Production and MEBO Metabolic Profiling are groundbreaking studies which explore innovative insight into conditions of malodor andor PATM. The study Exploratory Study of Relationships Between Malodor and Urine Metabolomics ClinicalTrials. gov IdentifierNCT02683876 was created to identifying metabolic signatures associated with malodor conditions.